Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Gastroparesis Outcome Longitudinal Database Enrolled Numerically

NCT: NCT03876288 · RECRUITING

NCT IDNCT03876288
StatusRECRUITING
Start Date2013-01-01
Completion2028-01-01

Brief Summary

GOLDEN is a longitudinal database of patients with the symptoms (Sx) of gastroparesis (Gp) who were seen and recorded at the University of Louisville from 2012 and is ongoing. Patients are enrolled and followed by sequential numbers and may include legacy patients seen at other centers by some of the same team and who are reported as part of the series. Outcome relate to patients Sx, survival, quality of life and other measures as detailed below, over time. The study tracks patients regardless of treatment but specifically focuses on GI Neuromodulation (gastric electrical stimulation - GES), Immunotherapy (IVIG), and Pyloric therapies (pyloroplasty, endoscopic). If treatments were administered GOLDEN allows for examination and stratification of outcome by groups both at baseline and at follow up.

Frequently Asked Questions

What is Gastroparesis Outcome Longitudinal Database Enrolled Numerically?

Gastroparesis Outcome Longitudinal Database Enrolled Numerically is a clinical trial registered under NCT03876288. Current status: RECRUITING.

What is the status of NCT03876288?

The current status of NCT03876288 (Gastroparesis Outcome Longitudinal Database Enrolled Numerically) is: RECRUITING.

When did Gastroparesis Outcome Longitudinal Database Enrolled Numerically start?

Gastroparesis Outcome Longitudinal Database Enrolled Numerically started on 2013-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.